Article Cited by others

ORIGINAL ARTICLE

Treatment strategy for metastatic prostate cancer with extremely high PSA level: reconsidering the value of vintage therapy

Yamada Yasutaka, Sakamoto Shinichi, Amiya Yoshiyasu, Sasaki Makoto, Shima Takayuki, Komiya Akira, Suzuki Noriyuki, Akakura Koichiro, Ichikawa Tomohiko, Nakatsu Hiroomi

Year : 2018| Volume: 20| Issue : 5 | Page no: 432-437

   This article has been cited by
 
1 Primary metastatic prostate cancer between prognosis or adequate/proper medical therapy
Mahmoud Mustafa,Honood Abu Rass,Mothafr Yahya,Khaleel Hamdan,Yazan Eiss
World Journal of Surgical Oncology. 2021; 19(1)
[Pubmed]  [Google Scholar] [DOI]
2 Impact of access to novel therapies on the initial management of castrate-resistant prostate cancer: an Australian multicentre study
Edmond M. Kwan,Marie C. Semira,Alice R. T. Bergin,Christine Muttiah,Sophie Beck,Angelyn Anton,David Campbell,Shirley Wong,Mark Rosenthal,Peter Gibbs,Ben Tran
Internal Medicine Journal. 2019; 49(11): 1378
[Pubmed]  [Google Scholar] [DOI]
3 Clinical characterization of low prostate-specific antigen on prognosis in patients with metastatic castration-nave prostate cancer
Hirotake Kodama,Shingo Hatakeyama,Shintaro Narita,Masahiro Takahashi,Toshihiko Sakurai,Sadafumi Kawamura,Senji Hoshi,Masanori Ishida,Toshiaki Kawaguchi,Shigeto Ishidoya,Jiro Shimoda,Takuma Narita,Hiromi Sato,Koji Mitsuzuka,Tatsuo Tochigi,Norihiko Tsuchiya,Yoichi Arai,Tomonori Habuchi,Chikara Ohyama
Clinical Genitourinary Cancer. 2019;
[Pubmed]  [Google Scholar] [DOI]
4 Impact of nadir PSA level and time to nadir during initial androgen deprivation therapy on prognosis in patients with metastatic castration-resistant prostate cancer
Itsuto Hamano,Shingo Hatakeyama,Shintaro Narita,Masahiro Takahashi,Toshihiko Sakurai,Sadafumi Kawamura,Senji Hoshi,Masanori Ishida,Toshiaki Kawaguchi,Shigeto Ishidoya,Jiro Shimoda,Hiromi Sato,Koji Mitsuzuka,Tatsuo Tochigi,Norihiko Tsuchiya,Yoichi Arai,Tomonori Habuchi,Chikara Ohyama
World Journal of Urology. 2019;
[Pubmed]  [Google Scholar] [DOI]
5 Identification of a Radiosensitivity Molecular Signature Induced by Enzalutamide in Hormone-sensitive and Hormone-resistant Prostate Cancer Cells
Maryam Ghashghaei,Tamim M. Niazi,Adriana Aguilar-Mahecha,Kathleen Oros Klein,Celia M. T. Greenwood,Mark Basik,Thierry M. Muanza
Scientific Reports. 2019; 9(1)
[Pubmed]  [Google Scholar] [DOI]

 

Read this article